Rutgers Cancer Institute Begins Patient Enrollment for Clinical Trial to Treat Solid Tumors with a New Anti-Cancer Drug
News
Rutgers Cancer Institute in New Brunswick, New Jersey announced it is opening up enrollment for a new clinical trial to investigate ONC201, a novel anti-cancer drug designed by Oncoceutics Inc. The trial ... Read more